Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2010
03/18/2010WO2010028676A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028675A1 Use of tyrosinase ( 192-200 ) nonapeptide as a therapeutic agent
03/18/2010WO2010028674A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028673A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028672A1 Use of a peptide as a therapeutic agent
03/18/2010WO2010028671A1 Use of opiorphin as a therapeutic agent
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010028503A1 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
03/18/2010WO2010028487A1 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents
03/18/2010WO2010028432A1 Protocols for treating bone disorders
03/18/2010WO2010011622A9 Ophthalmic gallium compositions and methods of their use
03/18/2010WO2010010454A3 Crystalline forms of a 3-pyrrole substituted 2-indolinone malate salt
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2010008744A3 Antineoplastic combinations containing hki-272 and vinorelbine
03/18/2010WO2010005735A3 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment
03/18/2010WO2010003133A3 Cdk modulators
03/18/2010WO2009156863A3 Substituted tricyclic derivatives against neurodegenerative diseases
03/18/2010WO2009154697A3 Disc-1 pathway activators in the control of neurogenesis
03/18/2010WO2009146216A3 Antioxidant inflammation modulators: novel derivatives of oleanolic acid
03/18/2010WO2009137091A3 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders
03/18/2010WO2009135180A3 A method for generating reference controls for pharmacogenomic testing
03/18/2010WO2009133071A3 Polyelectrolyte with positive net charge for use as medicament and diagnostic for cancer
03/18/2010US20100069629 Pyrimidine derivatives as pi3k inhibitor and use thereof
03/18/2010US20100069628 Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy
03/18/2010US20100069504 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy
03/18/2010US20100069492 Production of ultrapure epa and polar lipids from largely heterotrophic culture
03/18/2010US20100069486 Anti-tumor composition
03/18/2010US20100069484 SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
03/18/2010US20100069481 Methods and compositions for the treatment of cancer
03/18/2010US20100069480 Methods and compositions for the treatment of cancer
03/18/2010US20100069478 Isoflavone derivatives and uses thereof
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069471 Chemically modified oligonucleotides
03/18/2010US20100069470 Identification of protein biomarkers associated with lymph node metastasis in colorectal cancer
03/18/2010US20100069458 Combination of lbh589 with other therapeutic agents for treating cancer
03/18/2010US20100069453 Certain Chemical Entities, Compositions, and Methods
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069442 Pyrazole compounds that modulate hsp90 activity
03/18/2010US20100069440 Pyridine non-classical cannabinoid compounds and related methods of use
03/18/2010US20100069427 Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods
03/18/2010US20100069426 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
03/18/2010US20100069423 Use of Chk2 Kinase Inhibitors for Cancer Treatment
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069412 Phosphonoxy quinazoline derivatives and their pharmaceutical use
03/18/2010US20100069411 Cancer treatment method
03/18/2010US20100069398 Combination therapy
03/18/2010US20100069395 Pyrazolo[1,5-a]pyrimidine-3-carboxylic acid compounds as protein kinase inhibitors
03/18/2010US20100069386 Modulators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069357 Pyrimidine compounds, compositions and methods of use
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069345 Lanthanide-porphyrin complexes as anti-tumor agents
03/18/2010US20100069344 Small molecule antagonists of bcl2 family proteins
03/18/2010US20100069340 Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
03/18/2010US20100069336 High penetration prodrug compositions of mustards and mustard-related compounds
03/18/2010US20100069333 Alpha-helix mimetics and method relating to the treatment of cancer stem cells
03/18/2010US20100069331 Treatment or prevention of cancer and precancerous disorders
03/18/2010US20100069330 Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation Inhibitors
03/18/2010US20100069328 Novel ortho-aminoanilides for the treatment of cancer
03/18/2010US20100069326 Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
03/18/2010US20100069324 Nanoparticle of glucidamin for treating tumor and preparation method thereof
03/18/2010US20100069317 Crystalline nemorubicin hydrochloride
03/18/2010US20100069316 Treatment for multiple myeloma
03/18/2010US20100069313 Novel powders based on vegetation water from olive oil production
03/18/2010US20100069302 Specific therapy and medicament using integrin ligands for treating cancer
03/18/2010US20100069301 Compositions and methods for treating pathologic angiogenesis and vascular permeability
03/18/2010US20100069300 C-Type Lectin Fold as a Scaffold for Massive Sequence Variation
03/18/2010US20100069298 Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
03/18/2010US20100069295 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
03/18/2010US20100069291 Combination comprising cndac (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent
03/18/2010US20100069288 Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival
03/18/2010US20100068317 Anticancer composition
03/18/2010US20100068314 Herbal composition for treating cd33+ acute and chronic myeloid leukemia and a method thereof
03/18/2010US20100068303 Treatment of cancer with bio and chemotherapy
03/18/2010US20100068302 Methods and compositions for the treatment of cancer
03/18/2010US20100068293 Milk ingredient enriched in polar lipids and uses thereof
03/18/2010US20100068272 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
03/18/2010US20100068265 Gelatin capsules comprising an acid
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068253 Bleomycin preparation for use against skin tumours
03/18/2010US20100068251 Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
03/18/2010US20100068239 Osteogenic Device for Inducing Bone Formation in Clinical Contexts
03/18/2010US20100068216 Method and Compositions for Stimulation of an Immune Response to gp100 using a Xenogeneic gp100 Antigen
03/18/2010US20100068211 Use of antiresorptive compounds to prevent ionizing radiation-induced activation of osteoclasts and resulting bone loss
03/18/2010US20100068207 DDR2 in Cancer Diagnosis, Detection and Treatment
03/18/2010US20100068206 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
03/18/2010US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies
03/18/2010US20100068198 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
03/18/2010US20100068197 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
03/18/2010US20100068194 Composition for in vivo transplantation for treatment of human cervical cancer comprising mononuclear cells derived from umbilical cord blood
03/18/2010US20100068186 High affinity telomerase t cell receptors
03/18/2010US20100068181 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068178 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068174 Combination with bis (thiohydrazide amides) for treating cancer
03/18/2010US20100068170 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 2211